Latest Production News

Variscan Mines secures key regulatory approval and expands its zinc exploration footprint with a major historic drillhole acquisition, backed by a $2.25 million capital raise.

Jameson Resources has made significant strides in advancing its Crown Mountain Hard Coking Coal Project, progressing environmental assessments and Indigenous partnerships while securing fresh capital to support development.

eMetals Limited has progressed its exploration at the Busia Gold Project in Uganda, initiating a second phase of soil sampling to better define a significant gold anomaly. The company ends the quarter with a solid cash position following strategic asset sales.

Santana Minerals reports robust progress on its Bendigo-Ophir Gold Project with an updated Pre-Feasibility Study, strategic land acquisitions, and a substantial capital raise, positioning the project for development in 2026.

Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.

Northern Minerals reports a robust Definitive Feasibility Study and secures conditional funding interest, positioning Browns Range as a critical supplier of heavy rare earths by 2028.

Helios Energy has restarted production at its Texas Presidio wells and identified new drilling targets, setting the stage for a dual-track development strategy that balances early cashflow with longer-term growth.

Spenda Limited reported a record $204 million in payment volumes for Q1 FY26 alongside a strategic cost reduction of 21% annualised. The quarter also saw a significant leadership change with the resignation of its Managing Director.

Regener8 Resources has completed Phase 1 soil sampling at its North Achilles project using advanced Ultrafine™ geochemical techniques, positioning itself to leverage strong metal prices and nearby discoveries in the Cobar Basin.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

Galilee Energy reported steady cash reserves and ongoing reservoir pressure monitoring at its Glenaras Gas Project, while exploring new funding and growth opportunities.